Amylyx Pharmaceuticals Inc (AMLX) Stock Price, Quote & News

Company Profile

Amylyx Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, engages in the discovery and development of treatment options for neurodegenerative diseases and endocrine conditions in the United States. It provides Avexitide, an investigational, first-in-class glucagon-like peptide-1, or GLP-1 receptor antagonist, which is in phase 3 clinical trial to treat post-bariatric hypoglycemia and congenital hyperinsulinism. The company also develops AMX0035, an oral, fixed-dose combination of so...

Industry: Drug Manufacturers - Specialty & Generic

Sector: Healthcare

Phone: 617 682 0917

Website: amylyx.com

Address:

55 Cambridge Parkway, Suite 6W, Cambridge, United States

Bigbossmann Aug. 19 at 10:36 AM

$AMLX Anybody have a good guess what the offering price will be? My guess is around $22.50-$25.00 range. The current market cap is at about$4B, which seems extremely high knowing that revenue probably won't be realized for at least another year or so. Also, it needs to get approved by the FDA first, which has it's risks.

0 · Reply

G101SPM Aug. 19 at 10:02 AM

$AMLX $35.05 bid. SELL/TAKE PROFIT ON 20% OF NET LONG POSITION. DAC (dollar average cost includes partial SELLS at profit to reduce net cost of invtmemt position to zero, https://stocktwits.com/G101SPM/message/662143270

0 · Reply

NWMoneymaker Aug. 19 at 9:22 AM

$AMLX Setting up nicely for the open at $37

0 · Reply

JeffreyCline730 Aug. 19 at 9:18 AM

$LUNR $AMLX $AMD $SOXL Intuitive Machines benefits from lunar-infrastructure and government space spending, Amylyx advances therapies for neurological diseases, AMD benefits from data-center and AI-chip demand, and SOXL provides leveraged semiconductor exposure. I'm watching NASA contracts, clinical milestones, AI capex, and semiconductor momentum.

0 · Reply

laaarsas Aug. 19 at 8:18 AM

$AMLX 40 today?!?

1 · Reply

Thepath87 Aug. 19 at 8:13 AM

$AMLX lyx need to watch more comedy movies.

0 · Reply

CarolinaShaw238 Aug. 19 at 7:03 AM

0 · Reply

ajmore Aug. 19 at 6:50 AM

$AMLX recall what happened in previous offering? stock went up 25%! why? because these offerings are most likely initiated by the brokers covering the stock, on demand from their clients. As Amylyx de-risked and targets raised with 2 more drugs in pipeline some want to take huge positions which not easy in open market with so much demand. lets see.

1 · Reply

Rmccall Aug. 19 at 5:11 AM

$AMLX hope this drops so I can load up. In for the long haul on this one. Love when they do offerings, lowers the price for more purchases. Just a sign of confidence they have gold in them hands.

0 · Reply

Innerchild Aug. 19 at 4:10 AM

$GDC Amine says I am fucked too. Price right now is under 2$, chatgpt says if buyout happens company is blocked from accepting lower than 100$ proposal, that the Bitcoin is real. $XOS $IPST $AMLX $SLE

1 · Reply

Amylyx price target raised to $39 from $30 at BofA

2026-08-18T20:05:24.000Z - 14 hours ago

Amylyx announces $350M common stock offering

Aug 18, 2026, 4:01 PM EDT - 14 hours ago

Amylyx Pharmaceuticals Announces $350.0 Million Proposed Public Offering of Common Stock

Aug 18, 2026, 3:44 PM EDT - 15 hours ago

Amylyx stock soars on GLP-1 success: here's why investors should sell

2026-08-18T19:05:08.000Z - 15 hours ago

Amylyx price target raised to $52 from $28 at Baird

2026-08-18T16:20:09.000Z - 18 hours ago

Amylyx price target raised to $55 from $34 at H.C. Wainwright

2026-08-18T16:05:36.000Z - 18 hours ago

Amylyx rises 49.1%

2026-08-18T15:20:14.000Z - 19 hours ago

Amylyx price target raised to $45 from $21 at Stifel

2026-08-18T14:54:32.000Z - 19 hours ago

Amylyx Shares Jump 45% Following Positive Phase 3 Trial Results for GLP-1 Blocker Avexitide

2026-08-18T14:10:10.000Z - 20 hours ago

Stifel views Amylyx data as ‘best-case scenario’

2026-08-18T14:05:36.000Z - 20 hours ago

Amylyx Phase 3 data support FDA approval, says Citi

2026-08-18T14:00:23.000Z - 20 hours ago

Amylyx rises 41.7%

2026-08-18T12:36:00.000Z - 22 hours ago

Amylyx up 28% at $27.50 after announcing Lucidity trial met primary endpoint

Aug 18, 2026, 8:00 AM EDT - 22 hours ago

Amylyx Pharmaceuticals Transcript: Study result

Aug 18, 2026, 8:00 AM EDT - 22 hours ago

Amylyx Pharmaceuticals Press release: Study result

Aug 18, 2026, 8:00 AM EDT - 22 hours ago

Amylyx Pharmaceuticals Slides: Study result

Aug 18, 2026, 7:23 AM EDT - 23 hours ago

Amylyx Stock Surges 21% After GLP-1 Drug Succeeds in Phase 3 Trial

Aug 18, 2026, 7:14 AM EDT - 23 hours ago

Amylyx drug cuts low blood sugar episodes in bariatric surgery patients in key trial

2026-08-18T11:06:53.000Z - 23 hours ago

Amylyx announces Lucidity Phase 3 trial met primary endpoint

Aug 18, 2026, 7:00 AM EDT - 23 hours ago

Amylyx Pharmaceuticals Announces Positive Topline Results from Phase 3 LUCIDITY Clinical Trial of Avexitide in Post-Bariatric Hypoglycemia

2026-08-17T20:05:16.000Z - 1 day ago

Amylyx to announce topline results from Phase 3 LUCIDITY trial of Avexitide

2026-08-17T20:05:12.000Z - 1 day ago

Amylyx up 17% after announcing expected results for Avexitide tomorrow

Aug 17, 2026, 4:01 PM EDT - 1 day ago

Amylyx Pharmaceuticals to Announce Topline Results from its Phase 3 LUCIDITY Clinical Trial of Avexitide in Post-Bariatric Hypoglycemia on August 18, 2026

2026-08-17T10:50:49.000Z - 2 days ago

Amylyx price target raised to $30 from $24 at Mizuho

2026-08-10T11:06:17.000Z - 8 days ago

Amylyx price target raised to $30 from $22 at BofA

2026-08-07T11:56:09.000Z - 11 days ago

Amylyx price target raised to $28 from $19 at Baird

Aug 6, 2026, 8:00 AM EDT - 12 days ago

Amylyx Pharmaceuticals Earnings Call Transcript: Q2 2026

Aug 6, 2026, 8:00 AM EDT - 12 days ago

Amylyx Pharmaceuticals Earnings release: Q2 2026

Aug 6, 2026, 8:00 AM EDT - 12 days ago

Amylyx Pharmaceuticals Quarterly report: Q2 2026

Aug 6, 2026, 7:00 AM EDT - 12 days ago

Amylyx Pharmaceuticals Reports Second Quarter 2026 Financial Results

Aug 3, 2026, 9:00 AM EDT - 15 days ago

Amylyx Pharmaceuticals to Report Second Quarter 2026 Financial Results on August 6, 2026

Jul 3, 2026, 12:15 PM EDT - 6 weeks ago

Did Amylyx Pharmaceuticals, Inc. Insiders Breach their Fiduciary Duties to Shareholders?

Jun 23, 2026, 7:00 AM EDT - 2 months ago

Amylyx Pharmaceuticals to Present Data from First-in-Human, Dose-Ranging Phase 1 LUMINA Trial of AMX0114 in ALS at ENCALS 2026

Jun 10, 2026, 10:40 AM EDT - 2 months ago

Amylyx Pharmaceuticals Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026

Jun 8, 2026, 9:00 AM EDT - 2 months ago

Amylyx Pharmaceuticals Announces Poster Presentations at ENDO 2026

Jun 4, 2026, 9:00 AM EDT - 2 months ago

Amylyx Pharmaceuticals Transcript: AGM 2026

May 15, 2026, 12:11 PM EDT - 3 months ago

Amylyx Pharmaceuticals Announces Peer-Reviewed Publication of Phase 2 Open-Label HELIOS Trial Data for AMX0035 in The Journal of Clinical Investigation

May 13, 2026, 4:40 PM EDT - 3 months ago

Amylyx Pharmaceuticals Transcript: Bank of America Global Healthcare Conference 2026

May 7, 2026, 8:00 AM EDT - 3 months ago

Amylyx Pharmaceuticals Earnings Call Transcript: Q1 2026

May 7, 2026, 8:00 AM EDT - 3 months ago

Amylyx Pharmaceuticals Earnings release: Q1 2026

May 7, 2026, 8:00 AM EDT - 3 months ago

Amylyx Pharmaceuticals Quarterly report: Q1 2026

May 7, 2026, 7:00 AM EDT - 3 months ago

Amylyx Pharmaceuticals Reports First Quarter 2026 Financial Results

May 6, 2026, 9:00 AM EDT - 3 months ago

Amylyx Pharmaceuticals to Participate in Upcoming Investor Conferences

May 5, 2026, 7:00 AM EDT - 3 months ago

Amylyx Pharmaceuticals Announces U.S. Expanded Access Program for Adults with Post-Bariatric Hypoglycemia

Apr 30, 2026, 9:00 AM EDT - 3 months ago

Amylyx Pharmaceuticals to Report First Quarter 2026 Financial Results on May 7, 2026

Apr 23, 2026, 8:00 AM EDT - 4 months ago

Amylyx Pharmaceuticals Proxy statement: Proxy filing

Apr 23, 2026, 8:00 AM EDT - 4 months ago

Amylyx Pharmaceuticals Proxy statement: Proxy filing

Apr 15, 2026, 8:45 AM EDT - 4 months ago

Amylyx Pharmaceuticals Transcript: 25th Annual Needham Virtual Healthcare Conference

Apr 8, 2026, 9:00 AM EDT - 4 months ago

Amylyx Pharmaceuticals to Present at the 25th Annual Needham Virtual Healthcare Conference

Mar 24, 2026, 7:00 AM EDT - 5 months ago

Amylyx Pharmaceuticals Announces Completion of Enrollment in Pivotal Phase 3 LUCIDITY Clinical Trial of Avexitide in Post-Bariatric Hypoglycemia

Mar 10, 2026, 8:00 AM EDT - 5 months ago

Amylyx Pharmaceuticals Transcript: Leerink Global Healthcare Conference 2026

Mar 3, 2026, 11:10 AM EST - 6 months ago

Amylyx Pharmaceuticals Transcript: TD Cowen 46th Annual Health Care Conference

Mar 3, 2026, 8:00 AM EST - 6 months ago

Amylyx Pharmaceuticals Earnings Call Transcript: Q4 2025

Mar 3, 2026, 8:00 AM EST - 6 months ago

Amylyx Pharmaceuticals Annual report: Q4 2025

Mar 3, 2026, 8:00 AM EST - 6 months ago

Amylyx Pharmaceuticals Earnings release: Q4 2025

Mar 3, 2026, 7:00 AM EST - 6 months ago

Amylyx Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results

Mar 2, 2026, 6:00 AM EST - 6 months ago

Amylyx Pharmaceuticals Slides: Corporate presentation

Feb 26, 2026, 9:00 AM EST - 6 months ago

Amylyx Pharmaceuticals to Participate in Upcoming March Investor Conferences

Feb 24, 2026, 9:00 AM EST - 6 months ago

Amylyx Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results on March 3, 2026

Jan 29, 2026, 5:05 PM EST - 7 months ago

HALPER SADEH LLC ENCOURAGES AMYLYX PHARMACEUTICALS, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS

Jan 8, 2026, 7:00 AM EST - 7 months ago

Amylyx Pharmaceuticals Announces Nomination of AMX0318 as a Novel, Long-Acting GLP-1 Receptor Antagonist Development Candidate, Identified in Collaboration with Gubra A/S

Dec 5, 2025, 9:00 AM EST - 9 months ago

Amylyx Pharmaceuticals Announces New Safety and Tolerability Cohort 1 Data of AMX0114 in ALS from First-in-Human LUMINA Trial

Dec 3, 2025, 4:00 PM EST - 9 months ago

Amylyx Pharmaceuticals Transcript: Citi Annual Global Healthcare Conference 2025

Dec 2, 2025, 8:20 AM EST - 9 months ago

Amylyx Pharmaceuticals Transcript: Evercore ISI 8th Annual HealthCONx Conference

Nov 10, 2025, 4:30 PM EST - 10 months ago

Amylyx Pharmaceuticals Transcript: Guggenheim Securities 2nd Annual Healthcare Innovation Conference

Nov 6, 2025, 8:00 AM EST - 10 months ago

Amylyx Pharmaceuticals Earnings Call Transcript: Q3 2025

Nov 6, 2025, 8:00 AM EST - 10 months ago

Amylyx Pharmaceuticals Quarterly report: Q3 2025

Nov 6, 2025, 8:00 AM EST - 10 months ago

Amylyx Pharmaceuticals Earnings release: Q3 2025

Nov 6, 2025, 7:00 AM EST - 10 months ago

Amylyx Pharmaceuticals Reports Third Quarter 2025 Financial Results

Nov 3, 2025, 9:00 AM EST - 10 months ago

Amylyx Pharmaceuticals to Present at Upcoming Investor Conferences

Oct 30, 2025, 9:00 AM EDT - 10 months ago

Amylyx Pharmaceuticals to Report Third Quarter 2025 Financial Results on November 6, 2025

Oct 27, 2025, 12:20 PM EDT - 10 months ago

Halper Sadeh LLC Encourages Amylyx Pharmaceuticals, Inc. Shareholders to Contact the Firm to Discuss Their Rights

Sep 12, 2025, 7:30 AM EDT - 1 year ago

Amylyx Pharmaceuticals Slides: Corporate Presentation

Sep 10, 2025, 10:00 AM EDT - 1 year ago

Amylyx Pharmaceuticals Transcript: H.C. Wainwright 27th Annual Global Investment Conference

Sep 10, 2025, 12:06 AM EDT - 1 year ago

Amylyx Pharmaceuticals Announces Pricing of $175 Million Underwritten Public Offering of Common Stock

Sep 9, 2025, 4:01 PM EDT - 1 year ago

Amylyx Pharmaceuticals Announces Proposed Public Offering of Common Stock

Sep 9, 2025, 3:10 PM EDT - 1 year ago

Amylyx Pharmaceuticals Transcript: Baird Global Healthcare Conference 2025

Sep 8, 2025, 4:50 PM EDT - 1 year ago

Amylyx Pharmaceuticals Transcript: Morgan Stanley 23rd Annual Global Healthcare Conference

Sep 3, 2025, 8:00 AM EDT - 1 year ago

Amylyx Pharmaceuticals Transcript: Cantor Global Healthcare Conference 2025

Sep 2, 2025, 1:00 PM EDT - 1 year ago

Amylyx Pharmaceuticals Transcript: Citi's Biopharma Back to School Conference

Aug 27, 2025, 7:28 AM EDT - 1 year ago

Amylyx to stop development of rare brain disorder drug after trial failure

Aug 27, 2025, 7:00 AM EDT - 1 year ago

Amylyx Pharmaceuticals to Discontinue ORION Program of AMX0035 for Progressive Supranuclear Palsy (PSP)

Aug 7, 2025, 8:00 AM EDT - 1 year ago

Amylyx Pharmaceuticals Earnings Call Transcript: Q2 2025

Aug 7, 2025, 8:00 AM EDT - 1 year ago

Amylyx Pharmaceuticals Quarterly report: Q2 2025

Aug 7, 2025, 8:00 AM EDT - 1 year ago

Amylyx Pharmaceuticals Earnings release: Q2 2025

Aug 7, 2025, 7:00 AM EDT - 1 year ago

Amylyx Pharmaceuticals Reports Second Quarter 2025 Financial Results

Jul 31, 2025, 9:00 AM EDT - 1 year ago

Amylyx Pharmaceuticals to Report Second Quarter 2025 Financial Results on August 7, 2025

Jul 13, 2025, 9:00 PM EDT - 1 year ago

Amylyx Pharmaceuticals Transcript: Status Update

Jul 13, 2025, 9:00 PM EDT - 1 year ago

Amylyx Pharmaceuticals Press release: Status Update

Jul 13, 2025, 9:00 PM EDT - 1 year ago

Amylyx Pharmaceuticals Slides: Status Update

Jul 13, 2025, 5:00 PM EDT - 1 year ago

Amylyx Pharmaceuticals Presents New Exploratory Analyses from Phase 2 and Phase 2b Clinical Trials of Avexitide in Post-Bariatric Hypoglycemia at ENDO 2025

Jul 8, 2025, 7:00 AM EDT - 1 year ago

Amylyx Pharmaceuticals to Host Event to Discuss Post-bariatric Hypoglycemia and Avexitide at ENDO 2025

Jun 10, 2025, 3:20 PM EDT - 1 year ago

Amylyx Pharmaceuticals Transcript: Goldman Sachs 46th Annual Global Healthcare Conference

Jun 5, 2025, 1:25 PM EDT - 1 year ago

Amylyx Pharmaceuticals Transcript: Jefferies Global Healthcare Conference 2025

Jun 3, 2025, 7:00 AM EDT - 1 year ago

Amylyx Pharmaceuticals Receives U.S. FDA Fast Track Designation for AMX0114 for the Treatment of Amyotrophic Lateral Sclerosis

Bigbossmann Aug. 19 at 10:36 AM

0 · Reply

G101SPM Aug. 19 at 10:02 AM

0 · Reply

NWMoneymaker Aug. 19 at 9:22 AM

$AMLX Setting up nicely for the open at $37

0 · Reply

JeffreyCline730 Aug. 19 at 9:18 AM

0 · Reply

laaarsas Aug. 19 at 8:18 AM

$AMLX 40 today?!?

1 · Reply

Thepath87 Aug. 19 at 8:13 AM

$AMLX lyx need to watch more comedy movies.

0 · Reply

CarolinaShaw238 Aug. 19 at 7:03 AM

0 · Reply

ajmore Aug. 19 at 6:50 AM

1 · Reply

Rmccall Aug. 19 at 5:11 AM

$AMLX hope this drops so I can load up. In for the long haul on this one. Love when they do offerings, lowers the price for more purchases. Just a sign of confidence they have gold in them hands.

0 · Reply

Innerchild Aug. 19 at 4:10 AM

1 · Reply

Damondamon_ Aug. 19 at 3:52 AM

$AMLX This will remain dead 🤡 $GDC is the next 🇨🇳 runner 🚀 , our shorts are crying, PM is gonna be BRUTAL dont miss out Tiny float fresh Rs oh and 61% short volume ratio😉😉🩸 shes out for blood PM tmrw.

1 · Reply

Notespecially99 Aug. 19 at 3:35 AM

$AMLX Google Ai: ✅ Current Outstanding Shares: ~110.56 million shares.🗓️ Offering Timeline: Commenced on August 18, 2026; closing/completion dates depend on market conditions with no hard final date set yet.

0 · Reply

Damondamon_ Aug. 19 at 3:29 AM

$AMLX 😉 $GDC 👁️PM 🤫

0 · Reply

DataClown Aug. 19 at 3:23 AM

$AMLX Bullish — a clean Phase 3 win just turned a beaten-down 7 𝑏𝑖𝑜𝑡𝑒𝑐ℎ 𝑖𝑛𝑡𝑜 𝑎 2027 𝑙𝑎𝑢𝑛𝑐ℎ 𝑠𝑡𝑜𝑟𝑦.𝐴𝑛𝑑 𝑤ℎ𝑒𝑛 𝑚𝑎𝑛𝑎𝑔𝑒𝑚𝑒𝑛𝑡 𝑠𝑒𝑙𝑙𝑠 350M of stock into a 64% spike, even they think today's price is a gift.

0 · Reply

AlertsAndNews Aug. 19 at 3:11 AM

$AIXC $XOS $AMLX $TNON $OSRH Tomorrow is a new day. whats next?

0 · Reply

History101 Aug. 19 at 2:50 AM

$AMLX congrats Longs!! I had a small postion in AMLX, been in and out for a long time, and honestly was looking at adding the past few sessions when the announcement was made regarding this morning's PR. Added some today below $30, and I think it is going higher!! Again, great job Longs, I wish I had more!!

0 · Reply

ShKumaresan Aug. 19 at 1:55 AM

$AMLX $IOVA $OKE Why Did AMLX, IOVA, OKE Stocks Hit 52-Week Highs Today? https://stocktwits.com/news-articles/markets/equity/why-did-amlx-iova-oke-stocks-hit-52-week-highs-today/cZYdGjxRJkG

0 · Reply

StocktwitsNews Aug. 19 at 1:54 AM

Why Did AMLX, IOVA, OKE Stocks Hit 52-Week Highs Today? $AMLX $OKE $IOVA https://stocktwits.com/news/equity/markets/why-did-amlx-iova-oke-stocks-hit-52-week-highs-today/cZYdGjxRJkG

0 · Reply

Big_Mumma Aug. 19 at 1:43 AM

$AMLX Some scams are more organized than others

3 · Reply

Notespecially99 Aug. 19 at 1:34 AM

$AMLX Biotech companies

0 · Reply

topstockalerts Aug. 19 at 1:28 AM

Top Gainers PT2 $SLE $AMLX $GNLN $PSIG $EJH

1 · Reply

NWMoneymaker Aug. 19 at 1:19 AM

$AMLX shorts are fried if this opens at $36 and vault to $40

1 · Reply

Market Cap	2.39B
Revenue (ttm)	0.00
Net Income (ttm)	-144.74M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	23,960,199
Avg Vol	2,262,440
Day's Range	N/A - N/A
Shares Out	111.42M
Stochastic %K	98%
Beta	-0.21
Analysts	Strong Sell
Price Target	$28.40